119 related articles for article (PubMed ID: 8411824)
21. Results of local and/or systemic adjuvant therapy in the management of pathological stage C or D1 prostate cancer following radical prostatectomy.
Carter GE; Lieskovsky G; Skinner DG; Petrovich Z
J Urol; 1989 Nov; 142(5):1266-70; discussion 1270-1. PubMed ID: 2810504
[TBL] [Abstract][Full Text] [Related]
22. Value of and indications for pelvic lymph node dissection in the staging of prostate cancer.
Middleton RG
NCI Monogr; 1988; (7):41-3. PubMed ID: 3173502
[TBL] [Abstract][Full Text] [Related]
23. Radical excision of adenocarcinoma of prostate with pelvic lymph node involvement: surgical gesture or curative procedure.
Utz DC
Urology; 1984 Nov; 24(5 Suppl):4-11. PubMed ID: 6495469
[TBL] [Abstract][Full Text] [Related]
24. The patient, disease status, and treatment options for prostate cancer: stages D1 and D2.
Schmidt JD
Prostate; 1983; 4(5):493-501. PubMed ID: 6351040
[TBL] [Abstract][Full Text] [Related]
25. Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up.
Winter A; Henke RP; Wawroschek F
BMC Urol; 2015 Feb; 15(1):10. PubMed ID: 25881245
[TBL] [Abstract][Full Text] [Related]
26. One-stage laparoscopic pelvic lymphadenectomy and radical perineal prostatectomy.
Thomas R; Steele R; Smith R; Brannan W
J Urol; 1994 Oct; 152(4):1174-7. PubMed ID: 8072087
[TBL] [Abstract][Full Text] [Related]
27. Long-term results of a randomized trial for the treatment of Stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities.
Akakura K; Isaka S; Akimoto S; Ito H; Okada K; Hachiya T; Yoshida O; Arai Y; Usami M; Kotake T; Tobisu K; Ohashi Y; Sumiyoshi Y; Kakizoe T; Shimazaki J
Urology; 1999 Aug; 54(2):313-8. PubMed ID: 10443731
[TBL] [Abstract][Full Text] [Related]
28. [Complete radical prostatectomy and positive lymph nodes (stages pT1 to 4, N1 to 3, M0, D1)].
Feyaerts A; Stainier L; Nollevaux MC; De Groote P; Lorge F; Opsomer R; Wese FX; Cosyns JP; Van Cangh P
Acta Urol Belg; 1998 Mar; 66(1):1-6. PubMed ID: 9611351
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcome in patients with pTxN+ adenocarcinoma of prostate treated with radical prostatectomy and early androgen ablation.
Seay TM; Blute ML; Zincke H
J Urol; 1998 Feb; 159(2):357-64. PubMed ID: 9649239
[TBL] [Abstract][Full Text] [Related]
30. Observations on surgical management of carcinoma of prostate with limited nodal metastases.
Zincke H; Utz DC
Urology; 1984 Aug; 24(2):137-45. PubMed ID: 6464250
[TBL] [Abstract][Full Text] [Related]
31. VEGFR1 and NRP1 endothelial expressions predict distant relapse after radical prostatectomy in clinically localized prostate cancer.
Talagas M; Uguen A; Garlantezec R; Fournier G; Doucet L; Gobin E; Marcorelles P; Volant A; DE Braekeleer M
Anticancer Res; 2013 May; 33(5):2065-75. PubMed ID: 23645757
[TBL] [Abstract][Full Text] [Related]
32. Understaging and undergrading of prostate cancer. Argument for postoperative radiation as adjuvant therapy.
Lange PH; Narayan P
Urology; 1983 Feb; 21(2):113-8. PubMed ID: 6823718
[TBL] [Abstract][Full Text] [Related]
33. Radical prostatectomy and adjuvant radioactive gold seed placement: results of treatment at 5 and 10 years for clinical stages A2, B1 and B2 cancer of the prostate.
Kwon ED; Loening SA; Hawtrey CE
J Urol; 1991 Mar; 145(3):524-31. PubMed ID: 1997703
[TBL] [Abstract][Full Text] [Related]
34. Radical prostatectomy for stage D1 prostate cancer. Prognostic variables and results of treatment.
Golimbu M; Provet J; Al-Askari S; Morales P
Urology; 1987 Nov; 30(5):427-35. PubMed ID: 3672675
[TBL] [Abstract][Full Text] [Related]
35. [Recurrence following radical surgery for prostatic cancer. Analysis of clinical, biological and anatomo-pathological prognostic factors].
Feyaerts A; Delrée A; Lorge F; Opsomer RJ; Wese FX; Van Cangh PJ; Draguet AP; Cosyns JP
Acta Urol Belg; 1997 Mar; 65(1):11-8. PubMed ID: 9245198
[TBL] [Abstract][Full Text] [Related]
36. Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy.
Cadeddu JA; Partin AW; Epstein JI; Walsh PC
Urology; 1997 Aug; 50(2):251-5. PubMed ID: 9255297
[TBL] [Abstract][Full Text] [Related]
37. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA
Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
[TBL] [Abstract][Full Text] [Related]
38. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
[TBL] [Abstract][Full Text] [Related]
39. Radical prostatectomy for stage B2 prostatic cancer.
Middleton RG; Smith JA
J Urol; 1982 Apr; 127(4):702-3. PubMed ID: 7069834
[TBL] [Abstract][Full Text] [Related]
40. Significance of staging pelvic lymphadenectomy for prostatic cancer.
Fujioka T; Koike H; Aoki H; Ohhori T; Chiba R; Okamoto S
Urol Int; 1987; 42(5):380-4. PubMed ID: 3433586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
